Improving risk stratification of PI-RADS 3 + 1 lesions of the peripheral zone: expert lexicon of terms, multi-reader performance and contribution of artificial intelligence

Background: According to PI-RADS v2.1, peripheral PI-RADS 3 lesions are upgraded to PI-RADS 4 if dynamic contrast-enhanced MRI is positive (3+1 lesions), however those lesions are radiologically challenging. We aimed to define criteria by expert consensus and test applicability by other radiologists...

Full description

Saved in:
Bibliographic Details
Main Authors: Glemser, Philip (Author) , Netzer, Nils (Author) , Ziener, Christian H. (Author) , Wilhelm, Markus (Author) , Hielscher, Thomas (Author) , Zhang, Kevin Sun (Author) , Görtz, Magdalena (Author) , Schütz, Viktoria (Author) , Stenzinger, Albrecht (Author) , Hohenfellner, Markus (Author) , Schlemmer, Heinz-Peter (Author) , Bonekamp, David (Author)
Format: Article (Journal)
Language:English
Published: 19 August 2025
In: Cancer imaging
Year: 2025, Volume: 25, Pages: 1-14
ISSN:1470-7330
DOI:10.1186/s40644-025-00916-7
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1186/s40644-025-00916-7
Get full text
Author Notes:Philip A. Glemser, Nils Netzer, Christian H. Ziener, Markus Wilhelm, Thomas Hielscher, Kevin Sun Zhang, Magdalena Görtz, Viktoria Schütz, Albrecht Stenzinger, Markus Hohenfellner, Heinz-Peter Schlemmer and David Bonekamp
Description
Summary:Background: According to PI-RADS v2.1, peripheral PI-RADS 3 lesions are upgraded to PI-RADS 4 if dynamic contrast-enhanced MRI is positive (3+1 lesions), however those lesions are radiologically challenging. We aimed to define criteria by expert consensus and test applicability by other radiologists for sPC prediction of PI-RADS 3+1 lesions and determine their value in integrated regression models. Methods: From consecutive 3 Tesla MR examinations performed between 08/2016 to 12/2018 we identified 85 MRI examinations from 83 patients with a total of 94 PI-RADS 3+1 lesions in the official clinical report. Lesions were retrospectively assessed by expert consensus with construction of a newly devised feature catalogue which was utilized subsequently by two additional radiologists specialized in prostate MRI for independent lesion assessment. With reference to extended fused targeted and systematic TRUS/MRI-biopsy histopathological correlation, relevant catalogue features were identified by univariate analysis and put into context to typically available clinical features and automated AI image assessment utilizing lasso-penalized logistic regression models, also focusing on the contribution of DCE imaging (feature-based, bi- and multiparametric AI-enhanced and solely bi- and multiparametric AI-driven). Results: The feature catalog enabled image-based lesional risk stratification for all readers. Expert consensus provided 3 significant features in univariate analysis (adj. p-value <0.05; most relevant feature T2w configuration: “irregular/microlobulated/spiculated”, OR 9.0 (95%CI 2.3-44.3); adj. p-value: 0.016). These remained after lasso penalized regression based feature reduction, while the only selected clinical feature was prostate volume (OR<1), enabling nomogram construction. While DCE-derived consensus features did not enhance model performance (bootstrapped AUC), there was a trend for increased performance by including multiparametric AI, but not biparametric AI into models, both for combined and AI-only models. Conclusions: PI-RADS 3+1 lesions can be risk-stratified using lexicon terms and a key feature nomogram. AI potentially benefits more from DCE imaging than experienced prostate radiologists.
Item Description:Veröffentlicht: 19. August 2025
Gesehen am 14.01.2026
Physical Description:Online Resource
ISSN:1470-7330
DOI:10.1186/s40644-025-00916-7